IceCure reports 26% rise in ProSense sales, eyes FDA nod By Investing.com
CAESAREA, Israel - IceCure Medical Ltd. (NASDAQ:ICCM), a medical device company specializing in cryoablation technology, reported a 26% increase in product sales for the year ended December 31, 2023, compared to the previous year. The U.S.…
